Toni Ibrahim
Overview
Explore the profile of Toni Ibrahim including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
198
Citations
3574
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Caspani F, Cavalieri S, Orlandi E, Bergamini C, Resteghini C, Colombo E, et al.
Head Neck
. 2025 Mar;
PMID: 40033633
Background: Lenvatinib, a multi-target tyrosine kinase inhibitor (MTKI), has demonstrated activity in recurrent or metastatic (R/M) adenoid cystic carcinoma (ACC) in phase II studies. Methods: This multicenter, retrospective study included...
2.
Luksch R, Palmerini E, Milano G, Paioli A, Asaftei S, Barretta F, et al.
Pediatr Blood Cancer
. 2025 Jan;
72(4):e31551.
PMID: 39833645
Background: Several studies have shown that the intensity of treatment in Ewing sarcoma has an impact on outcome. The present trial tested the non-inferiority of intensive, shorter, induction chemotherapy (25 ...
3.
Morri M, Boccomino R, Brruku E, Bellina Terra A, Boschi R, Raucci G, et al.
Semin Oncol Nurs
. 2024 Dec;
41(1):151761.
PMID: 39665920
Objectives: The aim of the present study is to describe the course of fatigue syndrome in patients with musculoskeletal tumors starting from chemotherapy and to compare it with that of...
4.
Guerrieri A, Hattinger C, Marchesini F, Melloni M, Serra M, Ibrahim T, et al.
Int J Mol Sci
. 2024 Nov;
25(22).
PMID: 39596100
High-grade osteosarcoma (OS) is the most common primary bone tumor mainly affecting children and young adults. First-line treatment consists of neo-adjuvant chemotherapy with doxorubicin, cisplatin, and methotrexate and surgery. The...
5.
Palmerini E, Lopez Pousa A, Grignani G, Redondo A, Hindi N, Provenzano S, et al.
Cancer
. 2024 Nov;
131(1):e35628.
PMID: 39540661
Background: Herein, we present the results of the phase 2 IMMUNOSARC study (NCT03277924), investigating sunitinib and nivolumab in adult patients with advanced bone sarcomas (BS). Methods: Progressing patients with a...
6.
Ligero M, Hernando J, Delgado E, Garcia-Ruiz A, Merino-Casabiel X, Ibrahim T, et al.
BJC Rep
. 2024 Nov;
1(1):9.
PMID: 39516643
Background: More accurate predictive biomarkers in patients with gastroenteropancreatic neuroendocrine tumours (GEP-NETs) are needed. This study aims to investigate radiomics-based tumour phenotypes as a surrogate biomarker of the tumour vasculature...
7.
Giani C, Salawu A, Ljevar S, Denu R, Napolitano A, Palmerini E, et al.
Am J Surg Pathol
. 2024 Oct;
49(1):27-34.
PMID: 39466087
The aim of the study was to report the outcome of primary localized low-grade fibromyxoid sarcoma (LGFMS), sclerosing epithelioid fibrosarcoma (SEF), and hybrid LGFMS/SEF (H-LGFMS/SEF). Patients with primary localized LGFMS,...
8.
Giusti V, Miserocchi G, Sbanchi G, Pannella M, Hattinger C, Cesari M, et al.
Biomedicines
. 2024 Aug;
12(8).
PMID: 39200384
Musculoskeletal sarcomas pose major challenges to researchers and clinicians due to their rarity and heterogeneity. Xenografting human cells or tumor fragments in rodents is a mainstay for the generation of...
9.
Evangelisti G, Altorfer F, Falzetti L, Palmerini E, Griffoni C, Ghermandi R, et al.
J Clin Med
. 2024 Aug;
13(15).
PMID: 39124789
Surgical treatment of aneurysmal bone cysts (ABCs) can be challenging, especially in the spine. Non-surgical treatments such as with denosumab have shown promising results in different osteolytic pathologies. This retrospective...
10.
Vanni S, Miserocchi G, Gallo G, Fausti V, Gabellone S, Liverani C, et al.
Exp Hematol Oncol
. 2024 Aug;
13(1):74.
PMID: 39103896
Soft tissue sarcomas represent an heterogeneous group of rare mesenchymal tumors comprising 1% of all solid malignancies. Among them, liposarcoma is one of the most common histotypes with atypical lipomatous...